On October 29, 2009, United Therapeutics Corporation (the “Company”) issued a press release setting forth its earnings for the quarter ended September 30, 2009.
A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01. Exhibits
This information shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability under that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.
(d) Exhibits
|
Exhibit No. |
|
Description of Exhibit |
|
|
|
|
|
99.1 |
|
Press release dated October 29, 2009 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
UNITED THERAPEUTICS CORPORATION |
||
|
|
|
|
|
|
|
|
|
|
|
Dated: October 29, 2009 |
By: |
/s/ Paul A. Mahon |
|
|
|
Name: |
Paul A. Mahon |
|
|
|
Title: |
General Counsel |
|
Exhibit Index
|
Exhibit No. |
|
Description of Exhibit |
|
|
|
|
|
99.1 |
|
Press release dated October 29, 2009 |